In contrast, BARX2 expression was downregulated in breast invasive carcinoma (BRCA), colon adenocarcinoma (COAD), head and neck squamous cell carcinoma (HNSC), rectum adenocarcinoma (READ), and thyroid carcinoma (THCA). This evidence concerns the gene BARX2 and head and neck squamous cell carcinoma.